EUVIMEDEUVIMED entdecken
Scoping Review

Preferences for Parkinson’s Disease Treatments: A Scoping Literature Review

Pablo Arija, Marco Boeri, Connie H Yan, Zachary Baldwin

The Patient - Patient-Centered Outcomes Research · 2026-11 · 19 (6) · 775-789

DOI: 10.1007/s40271-026-00827-0 ↗

Kurz gefasst

Scoping Review in der Zeitschrift The Patient - Patient-Centered Outcomes Research, online erschienen am 22.07.2026. Verfasst von Pablo Arija und 3 weiteren Autor:innen. Beteiligte Einrichtung: Patient-Centered Outcomes, OPEN Health, Rotterdam, The Netherlands. pabloarija@openhealthgroup.com. Hauptthemen laut MEDLINE: Parkinson Disease, Patient Preference, Antiparkinson Agents. Die Arbeit nennt 34 Literaturangaben. Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms that significantly impact quality of life. As the disease advances, treatment options expand from oral medications to include device-aided therapies, which differ widely in their mechanisms, invasiveness, and impact on daily life. These therapies have distinct attributes that may align differently with individual patient preferences; therefore, understanding such preferences is crucial for informed, shared clinical decision making. This scoping review synthesizes quantitative evidence on treatment preferences among people with Parkinson’s disease (PwP), highlighting research gaps on key attributes.

Methods

A systematic search of PubMed and Embase (January 2026) identified studies using quantitative stated-preference methods—discrete choice experiments, best-worst scaling, conjoint analysis, or threshold techniques—with PwP, care partners, or healthcare professionals. Twelve studies met inclusion criteria.

Results

Treatment efficacy—particularly increased ‘ON time’ (periods without troublesome dyskinesia)—and treatment modality were the strongest drivers of preferences. PwP favored non-invasive treatments, such as oral or sublingual formulations, over surgical options like deep brain stimulation. Convenience factors, including pill burden and device management frequency, also influenced preferences but were generally secondary to efficacy and modality. Safety attributes, such as risk of depression or cognitive decline, were important but often outweighed by perceived benefits in symptom control. No studies assessed care partners’ preferences for modalities such as subcutaneous infusions.

Conclusions

PwP prioritize treatment efficacy and non-invasive modalities, with convenience and safety considered secondary. Further research should explore preferences for new treatment modalities and include care partners’ perspectives to optimize treatment planning and outcomes in PD care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseasePatient PreferenceAntiparkinson AgentsHumansQuality of LifeDeep Brain StimulationFemaleMale

Substanzen

Antiparkinson Agents

Autor:innen und Institutionen

  • Patient-Centered Outcomes, OPEN Health, Rotterdam, The Netherlands. pabloarija@openhealthgroup.com.
  • Patient-Centered Outcomes, OPEN Health, London, UK.
  • Health Economics, Queen's University, Belfast, UK.
  • AbbVie Inc., North Chicago, IL, USA.

Förderung

  • AbbVie

Zitieren

APA

Arija, P., Boeri, M., Yan, C. H., & Baldwin, Z. (2026). Preferences for Parkinson’s Disease Treatments: A Scoping Literature Review. The Patient - Patient-Centered Outcomes Research, 19(6), 775-789. https://doi.org/10.1007/s40271-026-00827-0

Vancouver

Arija P, Boeri M, Yan CH, Baldwin Z. Preferences for Parkinson’s Disease Treatments: A Scoping Literature Review. The Patient - Patient-Centered Outcomes Research. 2026;19(6):775-789. doi:10.1007/s40271-026-00827-0

BibTeX
@article{Arija2026,
  author = {Arija, Pablo and Boeri, Marco and Yan, Connie H and Baldwin, Zachary},
  title = {Preferences for Parkinson’s Disease Treatments: A Scoping Literature Review},
  journal = {The Patient - Patient-Centered Outcomes Research},
  year = {2026},
  volume = {19},
  number = {6},
  pages = {775--789},
  doi = {10.1007/s40271-026-00827-0}
}
Kostenlos starten →